AC
ONC

Allstate Corporation’s BeOne Medicines Ltd ONC Stock Holding History

Allstate Corporation’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,021
Closed -$292K – 724
2020
Q3 		$292K Buy
+1,021
New +$240K 0.01% 571
2020
Q1 		– Sell
-4,156
Closed -$689K – 705
2019
Q4 		$689K Buy
+4,156
New +$691K 0.01% 465

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Allstate Corporation's ONC Position: Q4 2020 in Review

Allstate Corporation sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 1,021 shares — an estimated $292K sold.

Allstate Corporation first reported a position in ONC in Q4 2019 and held it in 2 quarters. The position peaked at $689K in Q4 2019. 247 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Allstate Corporation reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Allstate Corporation sold 1,021 BeOne Medicines Ltd shares in Q4 2020, an estimated $292K.
  • Allstate Corporation first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 2 quarters.
  • Allstate Corporation's BeOne Medicines Ltd position peaked at $689K in Q4 2019.
  • 247 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Allstate Corporation's 13F filing for Q4 2020, filed 12 Feb 2021.